North America Infection Surveillance Solutions Market Size, Share & Industry Trends Analysis Report By Product & Services (Software (On-premise and Web-based Software) and Services), By End User, By Country and Growth Forecast, 2023 - 2029
The North America Infection Surveillance Solutions Market would witness market growth of 11.7% CAGR during the forecast period (2023-2029).
Software analysis tools are being used by hospitals & other healthcare facilities as a solution by examining several criteria and incorporating them for the implementation & estimation of public health practices to control the incidence of connected healthcare infections, infection surveillance analytics aid in the organization and interpretation of health data.
In addition, governments are anticipated to adopt these solutions due to the solutions' high degree of use and ability to support the development of the healthcare ecosystem. Information gathering, analysis, and interpretation about patients with various infections are made easier by infection surveillance systems for healthcare professionals. By disseminating information, they alert hospitals to hospital internet protocol and assist nurses & doctors in providing patient care.
They also assist in identifying antibiotic-resistant organisms (AROs), reduce the risk of respiratory tract infections, and guard against pneumonia from ventilators, surgical wounds, urinary tract infections, and bloodstream infusions. Additional features include precise employee health information, surgical databases, real-time access to medical records, and shifts in microbiological pathogens. Infection surveillance technologies also help spot epidemics.
One of the world's greatest marketplaces for medical technology research in North America. The region's massive market is largely due to expanding R&D in the medical sciences. Particularly in the U.S., Health and Human Services (HHS), overseen by the cabinet-level agency of the U.S. federal government, is especially liberal in financing & maintaining technological advancements in medical science. In addition, the U.S. Department of Health and Human Services (HHS) has made preventing and reducing healthcare-related diseases a primary focus. These factors are impacting the expansion of hospital technology, which are expected to boost the market for infection surveillance solutions in the North America region.
The US market dominated the North America Infection Surveillance Solutions Market by Country in 2022; thereby, achieving a market value of $381.7 Million by 2029. The Canada market is experiencing a CAGR of 13.8% during (2023 - 2029). Additionally, The Mexico market would exhibit a CAGR of 13.5% during (2023 - 2029).
Based on Product & Services, the market is segmented into Software (On-premise and Web-based Software) and Services. Based on End User, the market is segmented into Hospitals, Long-term Care Facilities and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Oracle Corporation (Cerner Corporation), Wolters Kluwer N.V., BioMérieux S.A., Baxter International, Inc., Harris Healthcare (Constellation Software, Inc.), Securitas AB, OSI Systems, Inc. (Spacelabs Healthcare), Gojo Industries, Inc. and Merative L.P. (Francisco Partners)
Scope of the Study
Market Segments covered in the Report:
By Product & Services
Software
On-premise
Web-based Software
Services
By End User
Hospitals
Long-term Care Facilities
Others
By Country
US
Canada
Mexico
Rest of North America
Companies Profiled
Becton, Dickinson and Company
Oracle Corporation (Cerner Corporation)
Wolters Kluwer N.V.
BioMérieux S.A.
Baxter International, Inc.
Harris Healthcare (Constellation Software, Inc.)
Securitas AB
OSI Systems, Inc. (Spacelabs Healthcare)
Gojo Industries, Inc.
Merative L.P. (Francisco Partners)
Unique Offerings from KBV Research
Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Infection Surveillance Solutions Market, by Product & Services
- 1.4.2 North America Infection Surveillance Solutions Market, by End User
- 1.4.3 North America Infection Surveillance Solutions Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition & Scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
- Chapter 4. North America Infection Surveillance Solutions Market by Product & Services
- 4.1 North America Software Market by Country
- 4.2 North America Infection Surveillance Solutions Market by Software Type
- 4.2.1 North America On-premise Market by Country
- 4.2.2 North America Web-based Software Market by Country
- 4.3 North America Services Market by Country
- Chapter 5. North America Infection Surveillance Solutions Market by End User
- 5.1 North America Hospitals Market by Country
- 5.2 North America Long-term Care Facilities Market by Country
- 5.3 North America Others Market by Country
- Chapter 6. North America Infection Surveillance Solutions Market by Country
- 6.1 US Infection Surveillance Solutions Market
- 6.1.1 US Infection Surveillance Solutions Market by Product & Services
- 6.1.1.1 US Infection Surveillance Solutions Market by Software Type
- 6.1.2 US Infection Surveillance Solutions Market by End User
- 6.2 Canada Infection Surveillance Solutions Market
- 6.2.1 Canada Infection Surveillance Solutions Market by Product & Services
- 6.2.1.1 Canada Infection Surveillance Solutions Market by Software Type
- 6.2.2 Canada Infection Surveillance Solutions Market by End User
- 6.3 Mexico Infection Surveillance Solutions Market
- 6.3.1 Mexico Infection Surveillance Solutions Market by Product & Services
- 6.3.1.1 Mexico Infection Surveillance Solutions Market by Software Type
- 6.3.2 Mexico Infection Surveillance Solutions Market by End User
- 6.4 Rest of North America Infection Surveillance Solutions Market
- 6.4.1 Rest of North America Infection Surveillance Solutions Market by Product & Services
- 6.4.1.1 Rest of North America Infection Surveillance Solutions Market by Software Type
- 6.4.2 Rest of North America Infection Surveillance Solutions Market by End User
- Chapter 7. Company Profiles
- 7.1 Becton, Dickinson and Company
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 Recent strategies and developments:
- 7.1.5.1 Partnerships, Collaborations, and Agreements:
- 7.1.5.2 Acquisition and Mergers:
- 7.1.5.3 Product Launches and Product Expansions:
- 7.1.6 SWOT Analysis
- 7.2 Oracle Corporation (Cerner Corporation)
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expense
- 7.2.5 Recent strategies and developments:
- 7.2.5.1 Partnerships, Collaborations, and Agreements:
- 7.2.6 SWOT Analysis
- 7.3 Wolters Kluwer N.V.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expenses
- 7.3.5 Recent strategies and developments:
- 7.3.5.1 Partnerships, Collaborations, and Agreements:
- 7.3.5.2 Product Launches and Product Expansions:
- 7.4 BioMérieux S.A.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expenses
- 7.4.5 Recent strategies and developments:
- 7.4.5.1 Partnerships, Collaborations, and Agreements:
- 7.4.5.2 Acquisition and Mergers:
- 7.4.5.3 Product Launches and Product Expansions:
- 7.5 Baxter International, Inc.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental Analysis
- 7.5.4 Research & Development Expense
- 7.5.5 Recent strategies and developments:
- 7.5.5.1 Partnerships, Collaborations, and Agreements:
- 7.5.5.2 Acquisition and Mergers:
- 7.6 Harris Healthcare (Constellation Software, Inc.)
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Regional Analysis
- 7.6.5 Recent strategies and developments:
- 7.6.5.1 Acquisition and Mergers:
- 7.7 Securitas AB
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.8 OSI Systems, Inc. (Spacelabs Healthcare)
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Segmental and Regional Analysis
- 7.8.4 Research & Development Expense
- 7.9 Gojo Industries, Inc.
- 7.9.1 Company Overview
- 7.10. Merative L.P. (Francisco Partners)
- 7.10.1 Company Overview
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook